Zydus Wellness fixes July 17 record date for ₹1.20 dividend

2 min read     Updated on 18 May 2026, 01:51 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Zydus Wellness Limited has fixed July 17, 2026, as the record date for a final dividend of ₹1.20 per share, pending shareholder approval at the AGM on August 4, 2026. The board also appointed Mr. Apurva S. Diwanji as an Additional Independent Director for a five-year term.

powered bylight_fuzz_icon
40636838

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has fixed Friday, July 17, 2026, as the record date to determine the eligibility of members entitled to receive the final dividend for the financial year ended March 31, 2026. The Board of Directors has recommended a final dividend of ₹1.20 per equity share, which is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).

Key Meeting Dates

The company has scheduled its Thirty Second AGM for Tuesday, August 4, 2026, at 10:00 a.m. IST via Video Conference or Other Audio Visual Means. Following the meeting, the payment of the dividend is expected to commence on or after Friday, August 7, 2026, subject to the deduction of applicable tax at source and shareholder approval.

Board Appointments

During its meeting held on May 18, 2026, the board approved the appointment of Mr. Apurva S. Diwanji as an Additional Director in the category of Non-Executive & Independent Director. His appointment is effective May 18, 2026, for a term of five years ending May 17, 2031, subject to approval by members through a special resolution. Mr. Diwanji will not be liable to retire by rotation.

Corporate Calendar

Event Date
Board Meeting May 18, 2026
Record Date July 17, 2026
Annual General Meeting August 4, 2026
Dividend Payment Start On or after August 7, 2026

Mr. Apurva S. Diwanji brings over 32 years of experience, specializing in mergers and acquisitions, private equity, and joint ventures. He currently serves as an Independent Director on the boards of Torrent Power Limited, Bajaj Life Insurance Limited, and Bajaj General Insurance Limited, among others.

How does Zydus Wellness's ₹1.20 per share dividend compare to its historical dividend payouts, and does this signal a shift in the company's capital allocation strategy?

Given Mr. Diwanji's extensive M&A and private equity expertise, could his appointment as Independent Director indicate that Zydus Wellness is exploring potential acquisitions or strategic partnerships in the near future?

How might Mr. Diwanji's simultaneous board memberships at Bajaj Life Insurance and Bajaj General Insurance create synergistic opportunities or conflicts of interest for Zydus Wellness's business interests?

like17
dislike

Zydus Wellness Schedules Q4FY26 Analyst & Investor Conference Call for May 18, 2026

1 min read     Updated on 10 May 2026, 12:53 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Zydus Wellness Limited has scheduled a teleconference call for analysts and institutional investors on May 18, 2026, at 4:00 p.m. IST, following the announcement of audited financial results for the quarter and financial year ended March 31, 2026. Facilitated by ICICI Securities, the call will feature Dr. Sharvil Patel (Chairman), Mr. Ganesh Nayak (Non-Executive Director), Mr. Tarun Arora (CEO), and Mr. Umesh Parikh (CFO), with dial-in access available across India, Singapore, Hong Kong, UK, and USA.

powered bylight_fuzz_icon
39876163

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has informed the stock exchanges of a scheduled teleconference call for analysts and institutional investors on Monday, May 18, 2026, at 4:00 p.m. IST. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated to both BSE Limited and the National Stock Exchange of India Limited. The call is to be held post the announcement of audited financial results for the quarter and financial year ended March 31, 2026.

Conference Call Details

The investor interaction will be facilitated by ICICI Securities and will feature senior representatives from Zydus Wellness Limited. The following key personnel are scheduled to participate in the call:

  • Dr. Sharvil Patel – Chairman
  • Mr. Ganesh Nayak – Non-Executive Director
  • Mr. Tarun Arora – CEO
  • Mr. Umesh Parikh – CFO

Access Information

Participants may join the conference call through the following dial-in numbers:

Region: Dial-In Number
Universal Access (India): +91 22 6280 1144; +91 22 7115 8045
Singapore (Toll Free): 8001012045
Hong Kong (Toll Free): 8009644448
UK (Toll Free): 08081011573
USA (Toll Free): 18667462133

ICICI Securities Coordinators

For any clarifications regarding the conference call, participants may reach out to the designated ICICI Securities coordinators:

Coordinator: Contact Details
Mr. Jaideep Goswami, Head of Equities: jaideep.goswami@icicisecurities.com
Mr. Manoj Menon, Head of Research: +91 22 6807 7209 | manoj.menon@icicisecurities.com
Mr. Akshay Krishnan: +91 22 6807 7632 | akshay.krishnan@icicisecurities.com
Mr. Rushad Kapadia: +91 22 6807 7334 | rushad.kapadia@icicisecurities.com

Regulatory Compliance

The filing was submitted to the exchanges on May 9, 2026, and signed by Nandish P. Joshi, Company Secretary and Compliance Officer of Zydus Wellness Limited. The communication was addressed to the Listing Departments of both BSE Limited and the National Stock Exchange of India Limited, in accordance with applicable disclosure requirements under SEBI regulations.

What revenue growth trajectory and margin expansion can investors expect from Zydus Wellness for FY2027 given the competitive pressures in the health and wellness FMCG segment?

How might Zydus Wellness's product portfolio strategy evolve following the FY2026 results, particularly in terms of new launches or acquisitions in the premium wellness category?

Will the management provide guidance on rural market penetration and distribution expansion plans that could drive volume growth in the upcoming fiscal year?

like17
dislike

More News on Zydus Wellness